Rise of Influencer Marketing: Patient Leaders Bring Value to Campaigns

Influencer marketing campaigns with patient leaders represent a significant opportunity to reach socially engaged, difficult-to-reach health audiences.

Building Insights for Patient Focused Drug Development: Understanding Patient Desires and Barriers

The COVID-19 pandemic continues to revolutionize the role of the patient voice in drug development and clinical trial creation and execution.

No Vacation from Condition Management: What Summer Means for Patients & Pharma

Patient perspectives on managing chronic condition(s) during the summer can help pharma marketers craft accurate, authentic, and season-specific messaging.

The Role of Social Media in Healthcare: Why Channel, Content, & Credibility are Key

Pharma marketers can harness the power of social media to reach patients where they are through credible, accurate, and engaging online content.

The True Impact of the COVID-19 Pandemic on the Immunocompromised

While COVID-19 has impacted people worldwide, there has been a particular focus over the past two years on people who are immunocompromised.

2022 Social Health Awards: How Pharma Can Give Back to Patient Leaders

Healthcare industry participation in the 2022 Social Health Awards will lay a strong foundation in emphasizing your commitment to patient centricity.

Innovation Through Social Learning in Healthcare

Health Union’s model of facilitating engagement supports social learning; it creates not just communities, but communities of practice.

Mental Health & Chronic Condition Management: How Social Health Provides Support

Patients are using social health on condition-specific online communities to conceptualize mental health awareness and support.

Understanding the Nuances of Social Health Use by Condition

Health Union survey data reveals trends in social health use by condition, creating opportunities for pharma to reach patients in the moments that matter.

How to Provide Value that Benefits Patients (and Your Brand)

While there are commonalities across the board, the top three resources that provide value for patients vary by therapeutic area and specific condition.